EUVIMEDEUVIMED entdecken
Crossref

How I diagnose and treat atypical hemolytic uremic syndrome

Fadi Fakhouri, Nora Schwotzer, Véronique Frémeaux-Bacchi iD

Blood · 02.03.2023 · 141 (9) · 984-995

DOI: 10.1182/blood.2022017860 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Blood, erschienen am 02.03.2023. Verfasst von Fadi Fakhouri und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Service of Nephrology and Hypertension, Lausanne University Hospital and Université de Lausanne, Lausanne, Switzerland. Hauptthemen laut MEDLINE: Atypical Hemolytic Uremic Syndrome. Die Arbeit wurde bisher 92-mal zitiert (Crossref) und nennt 93 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Our understanding and management of atypical hemolytic uremic syndrome (aHUS) have dramatically improved in the last decade. aHUS has been established as a prototypic disease resulting from a dysregulation of the complement alternative C3 convertase. Subsequently, prospective nonrandomized studies and retrospective series have shown the efficacy of C5 blockade in the treatment of this devastating disease. C5 blockade has become the cornerstone of the treatment of aHUS. This therapeutic breakthrough has been dulled by persistent difficulties in the positive diagnosis of aHUS, and the latter remains, to date, a diagnosis by exclusion. Furthermore, the precise spectrum of complement-mediated renal thrombotic microangiopathy is still a matter of debate. Nevertheless, long-term management of aHUS is increasingly individualized and lifelong C5 blockade is no longer a paradigm that applies to all patients with this disease. The potential benefit of complement blockade in other forms of HUS, notably secondary HUS, remains uncertain.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atypical Hemolytic Uremic SyndromeHumansRetrospective StudiesProspective StudiesComplement System ProteinsKidney

Substanzen

Complement System Proteins

Autor:innen und Institutionen

  • Department of Medicine, Service of Nephrology and Hypertension, Lausanne University Hospital and Université de Lausanne, Lausanne, Switzerland.
  • Laboratory of Immunology, Paris University, Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges-Pompidou, Paris, France.

ORCID-Profile: Véronique Frémeaux-Bacchi

Zitieren

APA

Fakhouri, F., Schwotzer, N., & Frémeaux-Bacchi, V. (2023). How I diagnose and treat atypical hemolytic uremic syndrome. Blood, 141(9), 984-995. https://doi.org/10.1182/blood.2022017860

Vancouver

Fakhouri F, Schwotzer N, Frémeaux-Bacchi V. How I diagnose and treat atypical hemolytic uremic syndrome. Blood. 2023;141(9):984-995. doi:10.1182/blood.2022017860

BibTeX
@article{Fakhouri2023,
  author = {Fakhouri, Fadi and Schwotzer, Nora and Frémeaux-Bacchi, Véronique},
  title = {How I diagnose and treat atypical hemolytic uremic syndrome},
  journal = {Blood},
  year = {2023},
  volume = {141},
  number = {9},
  pages = {984--995},
  doi = {10.1182/blood.2022017860}
}
Kostenlos starten →